You are viewing: Rest Of Europe Nuclear Medicine Equipment Market analysis

The Rest Of Europe Nuclear Medicine Equipment Market was valued at $310.9 Million in 2025 and projected to reach to $376.8 Million by 2030, representing a compound annual growth rate of 3.9%. Rest Of Europe's nuclear medicine equipment market demonstrates resilient growth driven by demographic aging and increasing healthcare investments across the region's diverse economies.

Rest Of Europe Nuclear Medicine Equipment Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Nuclear Medicine Equipment Market Trends and Insights

  • Rest Of Europe encompasses a diverse healthcare landscape with varying adoption rates of advanced diagnostic imaging technologies across multiple countries.
  • The region's growth is driven by aging populations, increasing prevalence of chronic diseases, and rising healthcare investments in modernizing diagnostic infrastructure. Rest Of Europe's nuclear medicine equipment market benefits from strong regulatory frameworks and established healthcare systems that support the deployment of SPECT and PET imaging systems.
  • Rest Of Europe is experiencing steady demand for both diagnostic and therapeutic nuclear medicine applications, particularly in oncology, cardiology, and neurology.
  • The market's moderate growth trajectory reflects Rest Of Europe's balanced approach to healthcare technology adoption, with established players maintaining presence alongside emerging regional manufacturers..

Key Market Statistics

  • CAGR (2025-2030) 3.9% CAGR
  • Market Size, 2025 ~USD 310.9 Million
  • Forecast, 2030 ~USD 376.8 Million
  • Country Rest Of Europe

Rest Of Europe Nuclear Medicine Equipment Market Overview

Market Valuation :

Rest Of Europe's nuclear medicine equipment market is valued at USD 310.9 million in 2025, with projections reaching USD 376.8 million by 2030, representing steady growth in the region's diagnostic imaging sector.

Regional Growth Rate :

The market expands at a CAGR of 3.9% through 2030, slightly below the global average of 4.62%, reflecting moderate but consistent adoption of nuclear medicine technologies across diverse European healthcare systems.

Healthcare Landscape Diversity :

Rest Of Europe encompasses multiple countries with varying healthcare infrastructure and technology adoption rates, creating both opportunities and challenges for nuclear medicine equipment manufacturers and distributors.

Aging Population Driver :

Demographic shifts toward an aging population across Rest Of Europe are increasing demand for advanced diagnostic imaging and nuclear medicine procedures, supporting sustained market expansion through 2030.

Rest Of Europe Nuclear Medicine Equipment Market Dynamics

  • The 3.9% CAGR reflects steady modernization of diagnostic imaging capabilities, though adoption rates vary significantly by country due to differences in healthcare funding and infrastructure development.
  • Key growth catalysts include rising prevalence of chronic diseases, expanding nuclear medicine applications, and gradual technology upgrades in aging hospital facilities. Looking ahead to 2030, the market will benefit from improved reimbursement policies, growing awareness of nuclear medicine's diagnostic value, and increased collaboration between healthcare providers and equipment manufacturers.
  • However, regional growth will remain tempered by economic disparities, regulatory complexities across multiple countries, and competition from alternative imaging modalities.
  • Strategic market entry and localized solutions will be critical for capturing growth opportunities in this fragmented but expanding market..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • Rest Of Europe's nuclear medicine equipment market will grow from USD 310.9M (2025) to USD 376.8M (2030) at a 3.9% CAGR.
    • Rest Of Europe demonstrates steady adoption of SPECT and PET imaging systems driven by aging demographics and chronic disease prevalence.
    • Rest Of Europe's healthcare infrastructure supports both diagnostic and therapeutic nuclear medicine applications across oncology, cardiology, and neurology.
    • Rest Of Europe's market growth reflects balanced technology adoption with established international players and emerging regional manufacturers competing for market share.

    Nuclear Medicine Equipment Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DIAGNOSTIC IMAGING CENTERS (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 4.62% from 2025 to 2030
    Largest Segment IMAGING MODALITIES (System Type)
    Market Size Base Year (Billions) ~USD 6.63 (2025)
    Revenue Forecast (Billions) ~USD 8.31 (2030)
    Segments Covered System Type, Type, Therapeutic Area, Dimension, End User, Type 2023–2030

    Rest Of Europe Nuclear Medicine Equipment Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By System Type

    • Imaging Modalities
    • Non- Imaging Modalities
    • Non-Imaging Modalities

    By Type

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gamma/Scintillation Cameras
    • Gm Counters
    • Hybrid Pet
    • Hybrid Spect
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect
    • Standalone Pet
    • Standalone Spect

    By Therapeutic Area

    • Cardiology
    • Neurology
    • Oncology
    • Orthopedics
    • Other Therapeutic Areas
    • Thyroid

    By Dimension

    • 2D
    • 3D

    By End User

    • Cancer Treatment Centers
    • Diagnostic Imaging Centers
    • Hospitals
    • Other End Users

    By Type 2023–2030

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gm Counters
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect

    Target Audience

    • Medical Device Manufacturers : Manufacturers of nuclear medicine equipment need Rest Of Europe-specific data to develop localized product strategies, identify distribution partnerships, and allocate R&D resources for regional market penetration.
    • Healthcare Facility Operators : Hospital administrators and diagnostic imaging center operators require market insights to justify capital investments in nuclear medicine equipment, benchmark against regional peers, and plan technology upgrades.
    • Investment & Private Equity Firms : Investors evaluating healthcare technology opportunities in Rest Of Europe need detailed market forecasts, growth drivers, and competitive landscapes to assess portfolio companies and identify acquisition targets.
    • Medical Equipment Distributors : Regional distributors and sales organizations require Rest Of Europe market analysis to optimize inventory, forecast demand by country, and develop effective sales strategies for nuclear medicine products.
    • Healthcare Policy & Regulatory Bodies : Government health agencies and regulatory organizations use market data to inform reimbursement policies, technology adoption guidelines, and healthcare infrastructure planning across Rest Of Europe.

    Key Companies in the Rest Of Europe Nuclear Medicine Equipment Market

    CompanyHQOwnershipStrongest segments
    PHILIPSNetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma),Software (Image Management, PACS, Treatment, Analytics, Workflow),Detectors & Counters (GM Counter, Dose Calibrator and Related),
    DIGIRAD CORPORATIONUnited StatesPrivate CompanyImaging – SPECT / Gamma cameras,Imaging – PET,Radiation detection (GM counters, dose calibrators),
    TOSHIBA CORPORATIONJapanPrivate CompanyImaging Equipment (PET, SPECT, Gamma),Radiation Measurement (GM Counter, Dose Calibrator),Software (Image Management, PACS, Treatment, Analytic, Workflow),
    SIEMENS AGGermanyPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Treatment, Analytics, Workflow),Therapy-adjacent Solutions (Onco, Cardio, Neuro, Ortho Planning/Support),
    GE HEALTHCAREUnited StatesPublic CompanyImaging – PET,Imaging – SPECT,Imaging – Gamma cameras,
    SIEMENS HEALTHINEERS AGGermany
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Analytics, Workflow, Treatment Planning Interfaces),Therapy-related Applications (Oncology, Cardiology, Neurology, Orthopedic Planning),
    MIRION TECHNOLOGIES, INC.United StatesPublic CompanyImaging-related equipment (PET/SPECT/Gamma-adjacent QA, detectors, cameras),Radiation measurement & counters (GM counters, dose calibrators, health-physics),Software (image/spectroscopy analysis, QA, workflow, treatment support),
    DOSISOFT SAFrancePrivate CompanyImaging-related software (PET/SPECT/Gamma image management & PACS integration),Treatment planning & dosimetry software (Onco/Cardio/Neuro/Ortho),Analytics & workflow orchestration,
    SEGAMI CORPORATIONJapanPrivate CompanyImaging Equipment (PET/SPECT/Gamma),GM Counters & Dose Calibrators,Nuclear Medicine Software (Image Management, PACS, Treatment, Analytic, Workflow),
    LABLOGIC SYSTEMS LTD.United KingdomPrivate CompanyImaging-adjacent QC hardware (gamma counters, dose calibrator-related QC, radiochromatography hardware),CDS / Image & data management software for radiopharmaceutical workflows,LIMS / workflow and analytic software for nuclear medicine and radiochemistry labs,

    PHILIPS

    Philips is a Dutch multinational public company founded in 1891 with 63,670 employees. The company operates across healthcare, consumer lifestyle, and lighting sectors.

    DIGIRAD CORPORATION

    Digirad Corporation is a United States-based private company founded in 1985 with 194 employees.

    TOSHIBA CORPORATION

    Toshiba Corporation is a Japanese private company founded in 1875 with 106,648 employees, operating across multiple industrial and technology sectors.

    SIEMENS AG

    Siemens AG is a German public company founded in 1847 with 310,312 employees, operating across industrial, infrastructure, and healthcare sectors.

    GE HEALTHCARE

    GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees.

    SIEMENS HEALTHINEERS AG

    Siemens Healthineers AG is a German healthcare company within the Siemens group.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 63,670 employees, operating across healthcare, consumer lifestyle, and lighting sectors.

    MIRION TECHNOLOGIES, INC.

    Mirion Technologies, Inc. is a United States-based public company founded in 2005 with 3,281 employees.

    DOSISOFT SA

    Dosisoft SA is a French private company founded in 2002.

    SEGAMI CORPORATION

    Segami Corporation is a Japanese private company with 1,501 employees.

    LABLOGIC SYSTEMS LTD.

    Lablogic Systems Ltd. is a United Kingdom-based private company founded in 1980.

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights specific to Rest Of Europe's nuclear medicine market, including country-level variations in adoption, regulatory environments, and healthcare spending patterns that differ from global averages.
    • Accurate Forecasting Data : Access precise market size estimates (USD 310.9M in 2025) and 5-year projections (USD 376.8M by 2030) with regional CAGR analysis to support strategic planning and investment decisions in Rest Of Europe.
    • Competitive Positioning Strategy : Understand Rest Of Europe's unique market dynamics, including aging demographics, healthcare infrastructure variations, and technology adoption rates to develop targeted go-to-market strategies and competitive advantages.
    • Growth Opportunity Identification : Identify high-potential segments and underserved markets within Rest Of Europe where nuclear medicine equipment demand is accelerating, enabling focused resource allocation and market expansion initiatives.
    • Risk Mitigation & Compliance : Navigate regional regulatory complexities, reimbursement variations, and healthcare policy differences across Rest Of Europe with comprehensive market intelligence to minimize market entry risks.

    Frequently asked questions

    What is the market size of nuclear medicine equipment in Rest Of Europe?

    Rest Of Europe's nuclear medicine equipment market is valued at USD 310.9 million in 2025 and is expected to reach USD 376.8 million by 2030.

    What is the growth rate for nuclear medicine equipment in Rest Of Europe?

    Rest Of Europe's nuclear medicine equipment market is projected to grow at a CAGR of 3.9% from 2025 to 2030.

    What are the primary drivers of growth in Rest Of Europe's nuclear medicine equipment market?

    Rest Of Europe's market growth is driven by aging populations, increasing chronic disease prevalence, rising healthcare investments, and modernization of diagnostic infrastructure across the region.

    Which applications dominate Rest Of Europe's nuclear medicine equipment market?

    Rest Of Europe experiences strong demand for nuclear medicine applications in oncology, cardiology, and neurology, supported by established healthcare systems and regulatory frameworks.

    Who are the key competitors in Rest Of Europe's nuclear medicine equipment market?

    Rest Of Europe's market includes established international manufacturers alongside emerging regional players, creating a competitive landscape with diverse product offerings and service capabilities.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the nuclear medicine equipment market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the nuclear medicine equipment market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Healthcare Information and Management Systems Society (HIMSS), Centers for Disease Control and Prevention (CDC), ClinicalTrials.gov, Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the nuclear medicine equipment market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

    Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.

    After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of nuclear medicine equipment offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

    In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

    Breakdown of Primary Interviews

    Nuclear Medicine Equipment Market

    Note 1: Other designations include sales, marketing, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product type, therapeutic area, dimension, end user, and region).

    Nuclear Medicine Equipment Market

    Data Triangulation

    After arriving at the overall market size, from the market size estimation process explained above, the nuclear medicine equipment market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the nuclear medicine equipment market.

    Market Definition

    Nuclear medicine equipment refers to specialized medical devices used to perform diagnostic and therapeutic procedures involving radioactive substances. These include imaging systems such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scanners, as well as gamma cameras and hybrid imaging systems. The equipment enables the detection, imaging, and tracking of radiopharmaceuticals within the body, playing a crucial role in disease diagnosis, monitoring, and targeted radionuclide therapy.

    Stakeholders

    • Nuclear Medicine Equipment Vendors & Imaging Device Manufacturers
    • Healthcare Providers (Hospitals, Outpatient Settings, Diagnostics & Imaging Centers, Radiopharmacies, Other Healthcare Providers)
    • Clinical Research Organizations (CROs)
    • Research & Development (R&D) Companies
    • Business Research & Consulting Service Providers
    • Medical Research Laboratories
    • Academic Medical Centers/Universities/Hospitals/Research Institutes
    • Regulatory Bodies (FDA, EMA, IAEA)
    • AI & Algorithm Developers
    • Venture Capitalists
    • Advocacy Groups
    • Investors & Financial Institutions
    • Contract Manufacturing Organizations (CMOs)
    • Contract Research Organizations (CROs)

    Report Objectives

    • To define, describe, and forecast the nuclear medicine equipment market by product type, therapeutic area, dimension, end user, and region
    • To provide detailed information regarding the major drivers, restraints, opportunities, and challenges influencing market growth
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall nuclear medicine equipment market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the nuclear medicine equipment market in five main regions (and their respective countries): North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
    • To provide key industry insights, such as supply chain, regulatory, patent, and recession impact analysis
    • To profile the key players in the market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches & upgrades, collaborations, partnerships, acquisitions, investments, contracts, agreements, alliances, mergers, funding, and expansions of the leading players in the market
    • To benchmark players within the market using the company evaluation matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Get the Full Nuclear Medicine Equipment Market Report

    Full forecast, segment splits, and company analysis for all Nuclear Medicine Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status